SAN || Clinical News

FVC inadequate when assessing scleroderma lung disease

Posted on: 18/06/2014 - 22:40

PARIS – The traditional way to assess the status of interstitial lung disease in patients with systemic sclerosis, forced vital capacity, may not be the best way, based on a new analysis of 83...

Field of Interest: Dermatology

Type: News Item

FVC inadequate when assessing scleroderma lung disease

Posted on: 18/06/2014 - 22:40

PARIS – The traditional way to assess the status of interstitial lung disease in patients with systemic sclerosis, forced vital capacity, may not be the best way, based on a new analysis of 83...

Field of Interest: Rheumatology

Type: News Item

TNF-alpha antagonists did not increase cancer risk in IBD

Posted on: 17/06/2014 - 21:00

The tumor necrosis factor–alpha antagonists infliximab, adalimumab, and certolizumab did not raise the risk of cancer in a nationwide Danish cohort study of patients with inflammatory bowel disease...

Field of Interest: Gastroentero...

Type: News Item

Treat to target shows durable improvements in psoriatic arthritis

Posted on: 12/06/2014 - 18:25

Thanks to anti–tumor necrosis factor inhibitors and other highly effective biologic therapies, rheumatologists are increasingly embracing treat to target, a strategy in which patients are closely...

Field of Interest: Rheumatology

Type: News Item

Copaxone lipoatrophy far more common than reported

Posted on: 09/06/2014 - 17:30

DALLAS – The risk of lipoatrophy with glatiramer acetate is greater than 60%, according to a review of 73 multiple sclerosis patients at one clinic. The risk is "substantially higher than...

Field of Interest: Dermatology

Type: News Item

Atopic dermatitis update taps top therapy choices

Posted on: 06/06/2014 - 22:05

WAIKOLOA, HAWAII – The 2014 update of the American Academy of Dermatology guidelines on atopic dermatitis take a strong stance in favor of the use of topical calcineurin inhibitors as topical...

Field of Interest: Dermatology

Type: News Item

Psoriasis patients on adalimumab show significant improvement by body region

Posted on: 06/06/2014 - 19:25

Roughly half of psoriasis patients on adalimumab showed complete resolution in specific body regions after 16 weeks, according to an analysis of the phase III CHAMPION trial reported in the May issue...

Field of Interest: Dermatology

Type: News Item

High rate of durable responses to pembrolizumab in metastatic melanoma

Posted on: 03/06/2014 - 19:35

CHICAGO – The investigational targeted agent pembrolizumab induced durable treatment responses in a high percentage of patients with advanced metastatic melanoma, in a phase I study. Of 411...

Field of Interest: Oncology

Type: News Item

FDA reclassifies tanning beds; warns against use by teens

Posted on: 29/05/2014 - 20:45

The Food and Drug Administration is requiring all tanning beds to carry a "black box" warning that the devices should not be used by children under age 18 years. The labeling doesn’t...

Field of Interest: Dermatology

Type: News Item

RA’s heterogeneity poses challenge to ‘personalized medicine’

Posted on: 28/05/2014 - 15:10

DESTIN, FLA. – Personalized medicine – picking the right patient for the right drug – is a hot topic in medicine in general, but the approach is challenging for rheumatoid arthritis because of its...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters